KYTHERA Biopharmaceuticals Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 4 of 4 Posts
Wednesday’s Pre-Market Insights: SGYP,YOKU, KYTH, HIMX
Article By: TipRanks Wednesday, June 17, 2015 9:23 AM EST
Wednesday’s Pre-Market Insights: Synergy Pharmaceuticals, Inc., Youku Tudou, Inc. (ADR), Kythera Biopharmaceuticals, Inc., Himax Technologies, Inc. (ADR).
In this article: HIMX, KYTH, SGYP, YOKU
Read
E Allergan Acquires Kythera Bio For $2.1 Billion
Article By: Terry Chrisomalis Wednesday, June 17, 2015 7:59 AM EST
Allergan announced today that it will buy Kythera Bio for $2.1 billion or $75 per share as a cash and equity type deal.
In this article: AGN, KYTH
Read
PFNX In Development Pact For Macular Degeneration Drug; KYTH Acquires Worldwide Rights To Potential Novel Treatment Of Hair Loss
Article By: BioMedReports Wednesday, February 11, 2015 7:05 AM EST
Pfenex Inc. In Development Pact For Macular Degeneration Drug, KYTHERA Acquires Worldwide Rights to Potential Novel Treatment of Hair Loss
In this article: PFNX, KYTH
Read
Fat Busting By Injection
Article By: IPO Candy Tuesday, November 18, 2014 1:42 PM EST
Neothetics is on the road now to fund the continued development of their injection-based approach to fat loss. It’s a smallish deal of $4.3M shares, with a $13-15 price range.
In this article: ZLTQ, KYTH
Read
1 to 4 of 4 Posts